Quetmolimab: A Deep Dive into KANAb 001 and E-6011 Quetmo compound, quetmolimab, represents a novel treatment focused on PD-1. Early study data from the two studies, KANAb 001 and E-6011, demonstrate positive activity https://www.targetmol.com/compound/quetmolimab